-
HCAT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Health Catalyst (HCAT)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 249.65 mm | 249.65 mm | 249.65 mm | 249.65 mm | 249.65 mm | 249.65 mm |
Cash burn (monthly) | 26.23 mm | (no burn) | 5.83 mm | 5.82 mm | 1.18 mm | (no burn) |
Cash used (since last report) | 54.37 mm | n/a | 12.09 mm | 12.06 mm | 2.44 mm | n/a |
Cash remaining | 195.28 mm | n/a | 237.55 mm | 237.59 mm | 247.21 mm | n/a |
Runway (months of cash) | 7.4 | n/a | 40.7 | 40.8 | 210.3 | n/a |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 157 |
Increased positions | 3 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 62.74 mm |
Total shares | 7.80 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
First Light Asset Management | 5.25 mm | $42.20 mm |
Wellington Management | 1.94 mm | $15.56 mm |
Point72 Asset Management | 619.02 k | $4.98 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 25 | Linda Llewelyn | Common Stock | Grant | Acquire A | No | No | 0 | 11,750 | 0.00 | 166,369 |
20 Feb 25 | Linda Llewelyn | Common Stock | Grant | Acquire A | No | No | 0 | 69,000 | 0.00 | 154,819 |
20 Feb 25 | LeSueur Daniel | Common Stock | Grant | Acquire A | No | No | 0 | 11,340 | 0.00 | 242,384 |
20 Feb 25 | LeSueur Daniel | Common Stock | Grant | Acquire A | No | No | 0 | 145,000 | 0.00 | 231,044 |
20 Feb 25 | Burton Daniel D. | Common Stock | Grant | Acquire A | No | No | 0 | 75,437 | 0.00 | 1,499,484 |
20 Feb 25 | Burton Daniel D. | Common Stock | Grant | Acquire A | No | No | 0 | 296,000 | 0.00 | 1,424,047 |
20 Feb 25 | Kevin Lee Freeman | Common Stock | Grant | Acquire A | No | No | 0 | 18,262 | 0.00 | 395,212 |
20 Feb 25 | Kevin Lee Freeman | Common Stock | Grant | Acquire A | No | No | 0 | 140,000 | 0.00 | 376,950 |
20 Feb 25 | Jason Alger | Common Stock | Grant | Acquire A | No | No | 0 | 11,950 | 0.00 | 279,662 |
20 Feb 25 | Jason Alger | Common Stock | Grant | Acquire A | No | No | 0 | 181,000 | 0.00 | 267,712 |